Market Research Logo

Cardiac Markers Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2018

Cardiac Markers Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, “Cardiac Markers Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2018 provides an overview of Cardiac Markers Rapid Tests & Point of Care (POC) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Markers Rapid Tests & Point of Care (POC) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cardiac Markers Rapid Tests & Point of Care (POC) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiac Markers Rapid Tests & Point of Care (POC) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiac Markers Rapid Tests & Point of Care (POC) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Cardiac Markers Rapid Tests & Point of Care (POC) Overview
3 Products under Development
3.1 Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development
3.2 Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Segment
3.3 Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Territory
3.4 Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Regulatory Path
3.5 Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Estimated Approval Date
4 Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products under Development by Companies
4.1 Cardiac Markers Rapid Tests & POC Companies - Pipeline Products by Stage of Development
4.2 Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development
5 Cardiac Markers Rapid Tests & Point of Care (POC) Companies and Product Overview
5.1 1Drop Diagnostics Company Overview
5.2 Abionic SA Company Overview
5.3 Accel Diagnostics LLC Company Overview
5.4 Akers Biosciences Inc Company Overview
5.5 Akrivis Technologies LLC Company Overview
5.6 Alfa Wassermann Inc Company Overview
5.7 Anteo Diagnostics Ltd Company Overview
5.8 Atonomics A/S Company Overview
5.9 Axela Inc Company Overview
5.10 Axis-Shield Diagnostics Ltd Company Overview
5.11 BBB Technologies Inc Company Overview
5.12 Bio-Alternative Medical Devices Ltd Company Overview
5.13 BioMedomics Inc Company Overview
5.14 BiOracle Ltd (Inactive) Company Overview
5.15 Biosensia Ltd Company Overview
5.16 Biostealth, Inc. Company Overview
5.17 Biosurfit, SA Company Overview
5.18 Carclo Diagnostic Solutions Ltd Company Overview
5.19 CardioGenics Inc Company Overview
5.20 Cordex Systems, LLC Company Overview
5.21 Critical Diagnostics Company Overview
5.22 Diazyme Laboratories Inc Company Overview
5.23 Duke University Company Overview
5.24 Dynasil Corporation of America Company Overview
5.25 Edan Instruments Inc Company Overview
5.26 Epinex Diagnostics Inc Company Overview
5.27 ET Healthcare, Inc. Company Overview
5.28 General Biologicals Corp Company Overview
5.29 Group K Diagnostics Company Overview
5.30 LeukoDx Ltd Company Overview
5.31 MML Ltd Company Overview
5.32 Nanomix Inc Company Overview
5.33 Novartis AG Company Overview
5.34 Ohmx Corp Company Overview
5.35 OPKO Health Inc Company Overview
5.36 Prolight Diagnostics AB Company Overview
5.37 QLIDA Diagnostics Company Overview
5.38 QuickCheck Health Inc Company Overview
5.39 Radiometer Medical ApS Company Overview
5.40 Radisens Diagnostics Ltd Company Overview
5.41 Resdin Technologies Inc. Company Overview
5.42 Sandia National Laboratories Company Overview
5.43 Sarissa-Biomedical Ltd Company Overview
5.44 Selfa, Inc. Company Overview
5.45 SpinChip Diagnostics AS Company Overview
5.46 Thermo Fisher Scientific Inc Company Overview
5.47 ThreeFold Sensors (Inactive) Company Overview
5.48 Trinity Biotech Plc Company Overview
5.49 True Diagnostics Inc Company Overview
5.50 Universal Biosensors Inc Company Overview
5.51 Upstream Medical Technologies Ltd Company Overview
5.52 XCellCure, LLC Company Overview
6 Cardiac Markers Rapid Tests & Point of Care (POC) - Recent Developments
6.1 May 14, 2018: Dynasil Corporation Of America Reports Second Quarter Fiscal 2018 Net Income Of $1.3 Million
6.2 May 01, 2018: Trinity Biotech announces Results for Q1, 2018
6.3 Apr 19, 2018: biomerieux - First-quarter 2018 Business Review
6.4 Mar 07, 2018: Trinity Biotech announces Quarter 4 and Fiscal Year 2017 Financial Results
6.5 Dec 20, 2017: Dynasil Corporation of America Reports Fiscal Year 2017 Financial Results
6.6 Nov 27, 2017: Beckman Coulter Enters Commercial Dispute with Quidde to Sell BNP Directly
6.7 Oct 26, 2017: Trinity Biotech Announces Results for Q3, 2017
6.8 Oct 18, 2017: bioMerieux - Business review for the nine months ended September 30, 2017
6.9 Sep 29, 2017: Alee Announces the U.S. Department of Justice Closes Investigation
6.10 Sep 28, 2017: Alee Announces Settlement with SEC
6.11 Aug 30, 2017: bioMerieux - First-Half 2017 Results
6.12 Aug 03, 2017: Alere Reports Second Quarter 2017 Financial Results
6.13 Jul 31, 2017: Sarissa And Aston University Receive A 2yr KTP Award To Develop An Automated SMARTChip Production Line.
6.14 Jul 20, 2017: bioMerieux - Second-Quarter 2017 Business Review
6.15 Jul 20, 2017: Trinity Biotech Announces Results for Q2, 2017
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development
Table 2: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Segment
Table 3: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Territory
Table 4: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Regulatory Path
Table 5: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Estimated Approval Date
Table 6: Cardiac Markers Rapid Tests & POC Companies - Pipeline Products by Stage of Development
Table 7: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development
Table 8: 1Drop Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
Table 9: One Drop Diagnostic Device - Cardiovascular Disease - Product Status
Table 10: One Drop Diagnostic Device - Cardiovascular Disease - Product Description
Table 11: Abionic SA Pipeline Products & Ongoing Clinical Trials Overview
Table 12: IVD CAPSULE - Thrombose Test - Product Status
Table 13: IVD CAPSULE - Thrombose Test - Product Description
Table 14: Accel Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 15: pScreen BNP - Product Status
Table 16: pScreen BNP - Product Description
Table 17: Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Diagnostic Test - Heart Attack - Product Status
Table 19: Diagnostic Test - Heart Attack - Product Description
Table 20: Akrivis Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Z-TECT - cTnI Assay - Product Status
Table 22: Z-TECT - cTnI Assay - Product Description
Table 23: Alfa Wassermann Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 24: ACE Alera Clinical Chemistry System - hsCRP Assay - Product Status
Table 25: ACE Alera Clinical Chemistry System - hsCRP Assay - Product Description
Table 26: ACE Axcel Clinical Chemistry System - hsCRP Assay - Product Status
Table 27: ACE Axcel Clinical Chemistry System - hsCRP Assay - Product Description
Table 28: Anteo Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 29: AtomoRapid - Heart Attack - Product Status
Table 30: AtomoRapid - Heart Attack - Product Description
Table 31: Point-Of-Care Troponin Test - Product Status
Table 32: Point-Of-Care Troponin Test - Product Description
Table 33: Atonomics A/S Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Premium Trace - B-type Natriuretic Peptide Assay - Product Status
Table 35: Premium Trace - B-type Natriuretic Peptide Assay - Product Description
Table 36: Trace - D-dimer Test - Product Status
Table 37: Trace - D-dimer Test - Product Description
Table 38: Axela Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Cardiac Troponin Biomarker Kit - Product Status
Table 40: Cardiac Troponin Biomarker Kit - Product Description
Table 41: Axis-Shield Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 42: Afinion hsCRP Assay - Product Status
Table 43: Afinion hsCRP Assay - Product Description
Table 44: BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 45: Mobile RDT Reader - Troponin-I Test - Product Status
Table 46: Mobile RDT Reader - Troponin-I Test - Product Description
Table 47: Bio-Alternative Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 48: Digital Strip Reader - Cardiac Marker - Product Status
Table 49: Digital Strip Reader - Cardiac Marker - Product Description
Table 50: Magnetic Immunoassay Detection System - Cardiac Myoglobin - Product Status
Table 51: Magnetic Immunoassay Detection System - Cardiac Myoglobin - Product Description
Table 52: Magnetic Immunoassay Detection System - Cardiac Troponin - Product Status
Table 53: Magnetic Immunoassay Detection System - Cardiac Troponin - Product Description
Table 54: Magnetic Immunoassay Detection System - CK MB - Product Status
Table 55: Magnetic Immunoassay Detection System - CK MB - Product Description
Table 56: BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 57: Point of Care Test - Troponin - Product Status
Table 58: Point of Care Test - Troponin - Product Description
Table 59: BiOracle Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 60: biO1042 Test - Product Status
Table 61: biO1042 Test - Product Description
Table 62: Biosensia Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 63: RapiPlex - Myoglobin Assay - Product Status
Table 64: RapiPlex - Myoglobin Assay - Product Description
Table 65: Biostealth, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 66: Point-Of-Care Assay - B-Type Natriuretic Peptide - Product Status
Table 67: Point-Of-Care Assay - B-Type Natriuretic Peptide - Product Description
Table 68: Biosurfit, SA Pipeline Products & Ongoing Clinical Trials Overview
Table 69: Spinit - D-dimer Test - Product Status
Table 70: Spinit - D-dimer Test - Product Description
Table 71: Carclo Diagnostic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 72: Micropoc-pro - Troponin-I Assay - Product Status
Table 73: Micropoc-pro - Troponin-I Assay - Product Description
Table 74: CardioGenics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 75: Heart Failure Risk Stratification Test - Product Status
Table 76: Heart Failure Risk Stratification Test - Product Description
Table 77: Cordex Systems, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 78: SmartCuff - Product Status
Table 79: SmartCuff - Product Description
Table 80: Critical Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
Table 81: Aspect - PLUS ST2 Test - Product Status
Table 82: Aspect - PLUS ST2 Test - Product Description
Table 83: Diazyme Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 84: ProADM Point-of-Care - Product Status
Table 85: ProADM Point-of-Care - Product Description
Table 86: Duke University Pipeline Products & Ongoing Clinical Trials Overview
Table 87: Multianalyte 2-D Diffusion Point-Of-Care Assay - Cardiac Infarction - Product Status
Table 88: Multianalyte 2-D Diffusion Point-Of-Care Assay - Cardiac Infarction - Product Description
Table 89: Dynasil Corporation of America Pipeline Products & Ongoing Clinical Trials Overview
Table 90: Diagnostic Test - Cardiovascular Risk - Product Status
Table 91: Diagnostic Test - Cardiovascular Risk - Product Description
Table 92: Edan Instruments Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 93: m16 - CRP Assay - Product Status
Table 94: m16 - CRP Assay - Product Description
Table 95: m16 - D-dimer Assay - Product Status
Table 96: m16 - D-dimer Assay - Product Description
Table 97: Epinex Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 98: Epinex G1A - Coronary Artery Disease Rapid Diagnostic Test - Product Status
Table 99: Epinex G1A - Coronary Artery Disease Rapid Diagnostic Test - Product Description
Table 100: ET Healthcare, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 101: Pylon Assay - High-sensitivity C-reactive Protein - Product Status
Table 102: Pylon Assay - High-sensitivity C-reactive Protein - Product Description
Table 103: Pylon Assay - High-sensitivity Troponin I - Product Status
Table 104: Pylon Assay - High-sensitivity Troponin I - Product Description
Table 105: Pylon Assay - NT-ProBNP - Product Status
Table 106: Pylon Assay - NT-ProBNP - Product Description
Table 107: General Biologicals Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 108: Point-Of-Care Diagnostic Assay - Troponin-I - Product Status
Table 109: Point-Of-Care Diagnostic Assay - Troponin-I - Product Description
Table 110: Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
1.2 List of Figures
Figure 1: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development
Figure 2: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Segment
Figure 3: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Territory
Figure 4: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Regulatory Path
Figure 5: Cardiac Markers Rapid Tests & Point of Care (POC) - Pipeline Products by Estimated Approval Date

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report